Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection
Article Abstract:
Treating HIV patients with the protease inhibitor nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz is more effective than using either drug alone, especially when combined with a third drug. This was the conclusion of a study of 195 HIV patients.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel
Article Abstract:
The International AIDS Society-USA has published updated guidelines on drug therapy for HIV infection. All HIV-infected patients whose CD4 cell counts have dropped below 500 should be treated. Initially, combinations of nucleoside analogs such as zidovudine, didanosine and zalcitabine should be used. Patients with more advanced disease could receive a nucleoside analog plus a protease inhibitor such as saquinavir, indinavir or ritonavir. Patients should be switched to another drug or drug combination if they experience severe side effects or become resistant to the initial drug.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Anti retroviral Therapy for HIV Infection in 1998, Part 2
Article Abstract:
The International AIDS Society-USA recommends early antiviral therapy, guided by viral load monitoring, for people infected with HIV. Patients effectively treated with a combination of protease inhibitor and reverse transcriptase inhibitor antiretroviral medications for over 2 years do not develop drug-resistant viral mutations. Early drug treatment substantially reduces hospitalizations and illness among HIV patients. Viral load monitoring can indicate the effectiveness of drug treatment regimens and guide changes in therapy.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: Recommendations of an international AIDS Society--USA Panel
- Abstracts: Selective termination for structural, chromosomal, and mendelian anomalies: international experience. Improvement in outcomes of multifetal pregnancy reduction with increased experience
- Abstracts: AsiaEs growing HIV/AIDS epidemics in spotlight at international conference. UN Conference Endorses Battle Plan for HIV/AIDS
- Abstracts: The troubled transformation of Britain's National Health Service. What's happening to Britain's National Health Service?
- Abstracts: Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus